Jeffrey Lu

Gründer bei

Goodman Capital Ltd.

Finance

Health Technology

Technology Services

Profil

Jeffrey Lu founded Goodman Capital Ltd. in 2013, where he is working as Advisor from 2013 and Engine Biosciences Pte Ltd. in 2016, where he is working as Chief Executive Officer & Director.
Mr. Lu also currently works at Pairx Bio Pte Ltd., as Founding Board Director from 2020 and Nest.Bio Ventures, as Venture Partner from 2017.
Mr. Lu also formerly worked at Think Big Analytics, Inc., as Board Director from 2012 to 2013 and Enleofen Bio Pte Ltd., as Director from 2017 to 2020.
Mr. Lu received his graduate degree from the University of Pennsylvania.

Aktive Positionen von Jeffrey Lu

Unternehmen	Position	Beginn
Goodman Capital Ltd. Goodman Capital Ltd. Investment ManagersFinance Goodman Capital invests in companies located in Asia and in the USA. The firm targets companies operating in the fields of tech, biotech and real estate sector. It provides financing for seed, early and later stage capital requirements.	Gründer	01.01.2013
Engine Biosciences Pte Ltd. Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes	Gründer	01.01.2016
Nest.Bio Ventures Nest.Bio Ventures Investment ManagersFinance Nest.Bio invests in companies located in the United States. The firm focuses on companies operating in the field of life science sector. It provides financing for early-stage capital requirements.	Private Equity Investor	01.01.2017
Pairx Bio Pte Ltd. Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins	Direktor/Vorstandsmitglied	01.01.2020

Alle aktiven Positionen von Jeffrey Lu

Ehemalige bekannte Positionen von Jeffrey Lu

Unternehmen	Position	Ende
Enleofen Bio Pte Ltd. Enleofen Bio Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics to treat fibrosis	Direktor/Vorstandsmitglied	01.01.2020
Think Big Analytics, Inc. Think Big Analytics, Inc. Packaged SoftwareTechnology Services Provides big data and advanced analytics consulting services	Direktor/Vorstandsmitglied	02.01.2013

Sehen Sie sich die Erfahrung von Jeffrey Lu im Detail an

Ausbildung von Jeffrey Lu

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jeffrey Lu im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	7
Think Big Analytics, Inc. Think Big Analytics, Inc. Packaged SoftwareTechnology Services Provides big data and advanced analytics consulting services	Technology Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Goodman Capital Ltd. Goodman Capital Ltd. Investment ManagersFinance Goodman Capital invests in companies located in Asia and in the USA. The firm targets companies operating in the fields of tech, biotech and real estate sector. It provides financing for seed, early and later stage capital requirements.	Finance
Engine Biosciences Pte Ltd. Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Develops novel combinations of genes and drugs for therapeutic and industrial purposes	Health Technology
Enleofen Bio Pte Ltd. Enleofen Bio Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics to treat fibrosis	Health Technology
Nest.Bio Ventures Nest.Bio Ventures Investment ManagersFinance Nest.Bio invests in companies located in the United States. The firm focuses on companies operating in the field of life science sector. It provides financing for early-stage capital requirements.	Finance
Pairx Bio Pte Ltd. Pairx Bio Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which develops and generates cancer immunotherapies targeting shared tumor-associated antigens derived from aberrantly spliced proteins	Commercial Services